EBR Systems Inc

Healthcare AU EBR

0.74AUD
0.005(0.68%)

Last update at 2026-03-13T05:10:00Z

Day Range

0.700.75
LowHigh

52 Week Range

0.642.08
LowHigh

Fundamentals

  • Previous Close 0.73
  • Market Cap472.49M
  • Volume702130
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-42.24198M
  • Revenue TTM0.68M
  • Revenue Per Share TTM0.002
  • Gross Profit TTM 0.31M
  • Diluted EPS TTM-0.18

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Income before tax -20.17269M -35.03526M -33.08660M -39.83537M -26.41608M
Minority interest - - - - -
Net income -20.17422M -35.03689M -33.08821M -39.83537M -25.71833M
Selling general administrative 5.82M 6.70M 5.41M 3.14M 12.57M
Selling and marketing expenses - 6.89M 8.11M 6.81M -
Gross profit - - - - -
Reconciled depreciation 0.97M 0.75M 0.65M 0.38M -
Ebit -38.31903M -25.41707M -24.27712M -15.24084M -20.58094M
Ebitda -37.73154M -24.66482M -23.62468M -14.85682M -
Depreciation and amortization 0.59M 0.75M 0.65M 0.38M -
Non operating income net other - - - - -
Operating income -38.31903M -34.54895M -24.27712M -15.24084M -20.58094M
Other operating expenses 19.02M 34.55M 27.39M 17.57M -
Interest expense 3.00M 4.48M 1.53M 19.01M 0.00000M
Tax provision 0.00153M 0.00162M 0.00160M 0.00000M -0.69775M
Interest income 3.18M 3.28M 2.46M 0.02M 6.46M
Net interest income -2.84868M -4.48373M 0.94M -18.99105M -
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 0.00153M 0.00162M 0.00160M 20.94M -0.69775M
Total revenue 0.00000M 0.00000M - 0.00000M 0.00000M
Total operating expenses 19.02M 34.55M 27.39M 17.57M -
Cost of revenue - - - - -
Total other income expense net -2.47771M -0.48632M -7.28321M -3.65871M -
Discontinued operations - - - - -
Net income from continuing ops -40.79827M -35.03689M -33.08821M -39.83537M -
Net income applicable to common shares - - -33.08821M -39.83537M -25.71833M
Preferred stock and other adjustments - - - - -
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Total assets 73.56M 78.90M 71.68M 85.42M 8.40M
Intangible assets - - - - -
Earning assets - - - - -
Other current assets 1.97M 0.38M 0.61M 0.17M 0.07M
Total liab 49.20M 47.84M 27.73M 9.53M 46.05M
Total stockholder equity 24.36M 31.06M 43.95M 75.90M -37.65058M
Deferred long term liab - - - - -
Other current liab 4.52M 4.32M 3.57M 3.01M -
Common stock 0.04M - 320.78M 319.41M 0.00132M
Capital stock 0.04M 342.75M 320.78M 319.41M -
Retained earnings -353.45768M -311.69613M -276.82768M -243.50751M -203.85144M
Other liab - - 0.48M - 7.15M
Good will - - - - -
Other assets - - 0.59M 0.44M 0.44M
Cash 6.92M 14.58M 15.46M 78.24M 5.88M
Cash and equivalents - - 15.46M 78.24M 5.88M
Total current liabilities 8.33M 6.45M 5.93M 7.32M 27.32M
Current deferred revenue - - - 0.00000M -
Net debt 34.48M 25.09M 6.13M -73.43513M -
Short term debt 0.56M - 0.27M 2.60M 0.00000M
Short long term debt 0.04M 0.02M 0.05M 2.41M -
Short long term debt total 41.40M - 21.59M 4.81M -
Other stockholder equity 376.90M - 0.79M 1.03M -0.08784M
Property plant equipment - - 3.52M 3.89M 0.89M
Total current assets 64.47M 74.37M 66.59M 81.10M 7.07M
Long term investments 5.30M 1.13M 0.99M - -
Net tangible assets - - 43.95M 75.90M -37.65906M
Short term investments 53.75M 57.74M 48.07M - -
Net receivables 0.44M 0.24M 0.44M 0.97M 0.27M
Long term debt 40.26M 39.65M 19.40M 0.07M 11.55M
Inventory 1.39M - 2.00M 1.72M -
Accounts payable 3.25M 1.86M 2.09M 1.71M 0.90M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 0.87M - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 2.06M 0.59M 0.59M 0.44M -
Deferred long term asset charges - - - - -
Non current assets total 9.09M 4.52M 5.09M 4.32M -
Capital lease obligations 1.10M 1.92M 2.14M 2.32M -
Long term debt total - - 19.40M 0.07M 11.55M
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Investments 1.11M -8.64099M -49.34781M -0.90681M -48.61763M
Change to liabilities - - 0.73M 0.72M -0.47901M
Total cashflows from investing activities 1.11M -8.64099M -49.34781M -0.90681M -0.26530M
Net borrowings 0.04M 20.00M 17.60M 20.02M 16.50M
Total cash from financing activities 32.48M 40.47M 17.01M 95.76M 16.41M
Change to operating activities - - 0.42M 0.39M 1.53M
Net income -40.79827M -0.03504M -33.08821M -39.83537M -25.71833M
Change in cash -7.66121M -0.87759M -62.78600M 72.36M -1.40722M
Begin period cash flow 14.58M 15.46M 78.24M 5.88M -
End period cash flow 6.92M 14.58M 15.46M 78.24M 5.88M
Total cash from operating activities -41.22982M -32.69751M -30.35592M -22.14939M -17.54706M
Issuance of capital stock 34.02M 21.62M 0.42M 80.93M -
Depreciation 0.97M 0.00117M 0.65M 0.38M 0.25M
Other cashflows from investing activities 1.39M -8.28694M -48.61763M 0.00520M -
Dividends paid - - -20.00000M -22.42455M -
Change to inventory -2.84254M 0.00000M - - 2.84M
Change to account receivables -0.21484M 0.09M - - -
Sale purchase of stock 34.51M 0.05M -0.21333M -4.90158M 0.01M
Other cashflows from financing activities -1.57479M -2.14910M 19.21M 22.13M -0.10752M
Change to netincome - - 0.31M -0.70866M -0.98268M
Capital expenditures 0.27M 0.35M 0.73M 0.91M 0.27M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -2.14179M 0.00078M 1.15M 1.11M 3.89M
Stock based compensation 1.74M 0.00131M - - -
Other non cash items -0.99907M -32.66573M - - -
Free cash flow -41.50326M -33.05157M -0.73018M -0.91201M -

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
EBR
EBR Systems Inc
0.005 0.68% 0.74 - - 485.39 6.05 326.08 -3.6785
COH
Cochlear Ltd
-4.74 2.65% 174.42 33.10 26.39 4.88 6.04 5.59 23.13
4DX
4DMEDICAL Ltd
-0.15 3.55% 4.07 - - 401.92 37.59 417.71 -7.2899
AVR
Anteris Technologies Global Corp
- -% 9.10 - - 475.96 166.77 334.65 -5.1986
PNV
Polynovo Ltd
- -% 0.94 94.00 30.21 4.66 7.81 4.68 93.96

Reports Covered

Stock Research & News

Profile

EBR Systems, Inc. develops implantable systems for wireless tissue stimulation. The company offers WiSE cardiac resynchronization therapy system, an implantable cardiac pacing system able to provide stimulation to endocardial heart tissue for the correction of heart rhythm conditions without requiring the use of wires or leads; and SOLVE-CRT, an investigational device exemption. The company was incorporated in 2003 and is headquartered in Sunnyvale, California.

EBR Systems Inc

480 Oakmead Parkway, Sunnyvale, CA, United States, 94085

Key Executives

Name Title Year Born
Mr. Allan R. Will Exec. Chairman 1954
Mr. John G. McCutcheon Pres, CEO & Director 1961
Mr. Frank Hettmann Chief Financial Officer NA
Mr. Michael Hendricksen Chief Operating Officer NA
Dr. N. Parker Willis Ph.D. Chief Technical Officer NA
Mr. Andrew Shute Sr. VP of Global Field Operations NA
Ms. Madhuri Bhat Chief Regulatory Officer NA
Dr. Spencer H. Kubo M.D. Chief Medical Officer NA
Mr. Steve Sandweg Chief Commercial Officer NA
Mr. John H. Sellers Sec. NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.